- call +1-201-465-4211
- email sales@mrinsights.biz
According to this study, over the next five years the Transdermal Drug Patches market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Transdermal Drug Patches business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Transdermal Drug Patches market by type, application, key manufacturers and key regions and countries.
This study considers the Transdermal Drug Patches value and volume generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Fentanyl Transdermal Patch
Nicotine Transdermal Patch
Buprenorphine Transdermal Patch
Clonidine Transdermal Patch
Oxybutynin Transdermal Patch
Others
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Used for Hypertension
Used for Contraception
Used for Analgesia
Used for Smoking Cessation
Used for Angina
Used for Hormone Replacement
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Noven
DURECT Corporation
Mylan
Johnson & Johnson
Agile Therapeutics
Novartis
Hercon Pharmaceuticals
Teikoku Pharma USA
Pocono
Immune Pharmaceuticals
Xel Pharmaceuticals
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Transdermal Drug Patches consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Transdermal Drug Patches market by identifying its various subsegments.
Focuses on the key global Transdermal Drug Patches manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Transdermal Drug Patches with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Transdermal Drug Patches submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Transdermal Drug Patches Consumption 2015-2025
2.1.2 Transdermal Drug Patches Consumption CAGR by Region
2.2 Transdermal Drug Patches Segment by Type
2.2.1 Fentanyl Transdermal Patch
2.2.2 Nicotine Transdermal Patch
2.2.3 Buprenorphine Transdermal Patch
2.2.4 Clonidine Transdermal Patch
2.2.5 Oxybutynin Transdermal Patch
2.2.6 Others
2.3 Transdermal Drug Patches Consumption by Type
2.3.1 Global Transdermal Drug Patches Consumption Market Share by Type (2015-2020)
2.3.2 Global Transdermal Drug Patches Revenue and Market Share by Type (2015-2020)
2.3.3 Global Transdermal Drug Patches Sale Price by Type (2015-2020)
2.4 Transdermal Drug Patches Segment by Application
2.4.1 Used for Hypertension
2.4.2 Used for Contraception
2.4.3 Used for Analgesia
2.4.4 Used for Smoking Cessation
2.4.5 Used for Angina
2.4.6 Used for Hormone Replacement
2.5 Transdermal Drug Patches Consumption by Application
2.5.1 Global Transdermal Drug Patches Consumption Market Share by Type (2015-2020)
2.5.2 Global Transdermal Drug Patches Value and Market Share by Type (2015-2020)
2.5.3 Global Transdermal Drug Patches Sale Price by Type (2015-2020)
3 Global Transdermal Drug Patches by Company
3.1 Global Transdermal Drug Patches Sales Market Share by Company
3.1.1 Global Transdermal Drug Patches Sales by Company (2018-2020)
3.1.2 Global Transdermal Drug Patches Sales Market Share by Company (2018-2020)
3.2 Global Transdermal Drug Patches Revenue Market Share by Company
3.2.1 Global Transdermal Drug Patches Revenue by Company (2018-2020)
3.2.2 Global Transdermal Drug Patches Revenue Market Share by Company (2018-2020)
3.3 Global Transdermal Drug Patches Sale Price by Company
3.4 Global Transdermal Drug Patches Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Transdermal Drug Patches Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Transdermal Drug Patches Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Transdermal Drug Patches by Regions
4.1 Transdermal Drug Patches by Regions
4.2 Americas Transdermal Drug Patches Consumption Growth
4.3 APAC Transdermal Drug Patches Consumption Growth
4.4 Europe Transdermal Drug Patches Consumption Growth
4.5 Middle East & Africa Transdermal Drug Patches Consumption Growth
5 Americas
5.1 Americas Transdermal Drug Patches Consumption by Countries
5.1.1 Americas Transdermal Drug Patches Consumption by Countries (2015-2020)
5.1.2 Americas Transdermal Drug Patches Value by Countries (2015-2020)
5.2 Americas Transdermal Drug Patches Consumption by Type
5.3 Americas Transdermal Drug Patches Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Transdermal Drug Patches Consumption by Regions
6.1.1 APAC Transdermal Drug Patches Consumption by Regions (2015-2020)
6.1.2 APAC Transdermal Drug Patches Value by Regions (2015-2020)
6.2 APAC Transdermal Drug Patches Consumption by Type
6.3 APAC Transdermal Drug Patches Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Transdermal Drug Patches by Countries
7.1.1 Europe Transdermal Drug Patches Consumption by Countries (2015-2020)
7.1.2 Europe Transdermal Drug Patches Value by Countries (2015-2020)
7.2 Europe Transdermal Drug Patches Consumption by Type
7.3 Europe Transdermal Drug Patches Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Transdermal Drug Patches by Countries
8.1.1 Middle East & Africa Transdermal Drug Patches Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Transdermal Drug Patches Value by Countries (2015-2020)
8.2 Middle East & Africa Transdermal Drug Patches Consumption by Type
8.3 Middle East & Africa Transdermal Drug Patches Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Transdermal Drug Patches Distributors
10.3 Transdermal Drug Patches Customer
11 Global Transdermal Drug Patches Market Forecast
11.1 Global Transdermal Drug Patches Consumption Forecast (2021-2025)
11.2 Global Transdermal Drug Patches Forecast by Regions
11.2.1 Global Transdermal Drug Patches Forecast by Regions (2021-2025)
11.2.2 Global Transdermal Drug Patches Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Transdermal Drug Patches Forecast by Type
11.8 Global Transdermal Drug Patches Forecast by Application
12 Key Players Analysis
12.1 Noven
12.1.1 Company Information
12.1.2 Transdermal Drug Patches Product Offered
12.1.3 Noven Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Noven Latest Developments
12.2 DURECT Corporation
12.2.1 Company Information
12.2.2 Transdermal Drug Patches Product Offered
12.2.3 DURECT Corporation Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 DURECT Corporation Latest Developments
12.3 Mylan
12.3.1 Company Information
12.3.2 Transdermal Drug Patches Product Offered
12.3.3 Mylan Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Mylan Latest Developments
12.4 Johnson & Johnson
12.4.1 Company Information
12.4.2 Transdermal Drug Patches Product Offered
12.4.3 Johnson & Johnson Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Johnson & Johnson Latest Developments
12.5 Agile Therapeutics
12.5.1 Company Information
12.5.2 Transdermal Drug Patches Product Offered
12.5.3 Agile Therapeutics Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Agile Therapeutics Latest Developments
12.6 Novartis
12.6.1 Company Information
12.6.2 Transdermal Drug Patches Product Offered
12.6.3 Novartis Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Novartis Latest Developments
12.7 Hercon Pharmaceuticals
12.7.1 Company Information
12.7.2 Transdermal Drug Patches Product Offered
12.7.3 Hercon Pharmaceuticals Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Hercon Pharmaceuticals Latest Developments
12.8 Teikoku Pharma USA
12.8.1 Company Information
12.8.2 Transdermal Drug Patches Product Offered
12.8.3 Teikoku Pharma USA Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Teikoku Pharma USA Latest Developments
12.9 Pocono
12.9.1 Company Information
12.9.2 Transdermal Drug Patches Product Offered
12.9.3 Pocono Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Pocono Latest Developments
12.10 Immune Pharmaceuticals
12.10.1 Company Information
12.10.2 Transdermal Drug Patches Product Offered
12.10.3 Immune Pharmaceuticals Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Immune Pharmaceuticals Latest Developments
12.11 Xel Pharmaceuticals
12.11.1 Company Information
12.11.2 Transdermal Drug Patches Product Offered
12.11.3 Xel Pharmaceuticals Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Xel Pharmaceuticals Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Transdermal Drug Patches Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Playe
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
